Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cysteamine Bitartrate
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Cyspera® Launches New Three-Step System with Novel Pigment Corrector to Treat Hyperpigmentation
Details : Cyspera (cysteamine) is the clinically proven to provide effective treatment of hyperpigmentation without the concerns of corticosteroids, retinoic-acid and hydroquinoneused to treat hyperpigmentation.
Product Name : Cyspera
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 17, 2022
Lead Product(s) : Cysteamine Bitartrate
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable